Oppenheimer Asset Management’s NeoGenomics NEO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-18,276	Closed	-$134K	–	1202
2025 Q2	$134K	Sell	18,276 -12,923	-41%	-$104K	﹤0.01%	1132
2025 Q1	$296K	Buy	31,199 +927	+3%	+$11.6K	﹤0.01%	965
2024 Q4	$499K	Sell	30,272 -2,350	-7%	-$36.5K	0.01%	861
2024 Q3	$481K	Buy	32,622 +117	+0.4%	+$1.83K	0.01%	891
2024 Q2	$451K	Buy	32,505 +1,030	+3%	+$14.6K	0.01%	881
2024 Q1	$495K	Buy	31,475 +3,899	+14%	+$60.2K	0.01%	839
2023 Q4	$446K	Buy	27,576 +7,998	+41%	+$131K	0.01%	891
2023 Q3	$241K	Buy	19,578 +6,062	+45%	+$90.1K	﹤0.01%	1009
2023 Q2	$217K	Buy	+13,516	New	+$223K	﹤0.01%	1047
2022 Q1	–	Sell	-7,262	Closed	-$248K	–	1234
2021 Q4	$248K	Buy	7,262 +26	+0.4%	+$1.02K	﹤0.01%	1124
2021 Q3	$349K	Sell	7,236 -14,272	-66%	-$661K	0.01%	1019
2021 Q2	$972K	Sell	21,508 -3,935	-15%	-$174K	0.01%	766
2021 Q1	$1.23M	Buy	25,443 +287	+1%	+$14.9K	0.02%	658
2020 Q4	$1.35M	Buy	25,156 +799	+3%	+$36.1K	0.02%	590
2020 Q3	$898K	Buy	24,357 +5,421	+29%	+$202K	0.02%	652
2020 Q2	$586K	Buy	18,936 +11,602	+158%	+$322K	0.01%	753
2020 Q1	$202K	Buy	7,334 +6,398	+684%	+$192K	0.01%	967
2019 Q4	$28K	Buy	936 +781	+504%	+$18.6K	﹤0.01%	1418
2019 Q3	$3K	Hold	155	–	–	﹤0.01%	1556
2019 Q2	$3K	Hold	155	–	–	﹤0.01%	1575
2019 Q1	$3K	Sell	155 -1,704	-92%	-$29.6K	﹤0.01%	1557
2018 Q4	$23K	Buy	+1,859	New	+$27.7K	﹤0.01%	1453
2017 Q4	–	Sell	-5,976	Closed	-$67K	–	1334
2017 Q3	$67K	Buy	5,976 +532	+10%	+$5.18K	﹤0.01%	1298
2017 Q2	$49K	Buy	5,444 +3,123	+135%	+$24.8K	﹤0.01%	1353
2017 Q1	$18K	Buy	+2,321	New	+$18.9K	﹤0.01%	1487